English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

I have great pleasure writing this opening to the special edition of the Australian Journal of Chemistry dedicated to nanomedicine. Many of you would be aware that I have been a part of the Centre for Advanced Macromolecular Design (CAMD) for 10 years. It was a privilege when the Executive of UNSW asked me to establish and co-direct a new research centre in nanomedicine – The Australian Centre for NanoMedicine (ACN) (Fig. 1). ACN has two key aims: first and foremost is as a research centre dedicated to finding solutions to provide a better way of life for those in our population afflicted with hard-to-treat diseases; and second to work with a diversity of stakeholder groups to communicate research findings and be an Australian hub for nanomedicine discussion and commentary. Both of these aims were central to ACN hosting the 2nd International NanoMedicine Conference from 14 to 16 July 2011. As we spent three glorious Sydney winter days overlooking Coogee Beach as whales undertook their northern migration before us, 200 attendees representing over 25 invited speakers, 30 posters and 10 nationalities discussed their research under the headings of targeted delivery, diagnostics, imaging, sensing, nanosafety, regenerative medicine, and a special session on translational medicine. For the second consecutive year, it was ACN’s pleasure to bring together the top minds in a discipline that crosses borders incorporating medicine, chemistry, and engineering and truly represents the adage of ‘bench to bedside’, but just as importantly ‘bedside to bench’. The first of four plenary speakers opened the conference program, this being Professor Mark Kendall of the Australian Institute of Bioengineering and Nanotechnology (AIBN) with his address onNanopatches for Target VaccineDelivery to Skin: Improving Vaccines. Day 1 ended with what is becoming just as famous as the quality of the research presented at this conference – and that is the quality of our networking events. Day 1’s welcome event did not disappoint as nervousness and barriers quickly disappeared, and discussions and friendships developed. Three more outstanding plenary sessions followed, with speakers including Professor Calum Drummond, CSIRO’s Group Executive, Manufacturing, Materials and Minerals; Professor Ian Frazer, Chief Executive Officer and Director of Research at the Translational Research Institute (TRI) Pty Ltd (Fig. 2); and Professor Justin Gooding of the Australian Centre for NanoMedicine, UNSW. It was a deliberate decision that the plenary speakers showcased the very best of Australian

Biomedical, Bio-Nano, Personalized Medicine – It's All Nanomedicine to Us!